| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC1 EP400 RNF213 ABCC9 MYO1B ACSL3 ABCG4 IQCA1L KIF2B DNAH17 SMARCA4 MORC3 DNAH9 YME1L1 | 4.07e-06 | 614 | 105 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC1 RNF213 ABCC9 ABCG4 IQCA1L KIF2B SMARCA4 MORC3 DNAH9 YME1L1 | 1.11e-04 | 441 | 105 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | actin filament binding | 1.98e-04 | 227 | 105 | 7 | GO:0051015 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCC1 HBS1L SEPTIN9 RNF213 ABCC9 ABCG4 IQCA1L KIF2B SMARCA4 MORC3 DNAH9 YME1L1 AGAP3 | 2.13e-04 | 775 | 105 | 13 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCC1 HBS1L SEPTIN9 RNF213 ABCC9 ABCG4 IQCA1L KIF2B SMARCA4 MORC3 DNAH9 YME1L1 AGAP3 | 4.56e-04 | 839 | 105 | 13 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCC1 HBS1L SEPTIN9 RNF213 ABCC9 ABCG4 IQCA1L KIF2B SMARCA4 MORC3 DNAH9 YME1L1 AGAP3 | 4.61e-04 | 840 | 105 | 13 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCC1 HBS1L SEPTIN9 RNF213 ABCC9 ABCG4 IQCA1L KIF2B SMARCA4 MORC3 DNAH9 YME1L1 AGAP3 | 4.61e-04 | 840 | 105 | 13 | GO:0016818 |
| GeneOntologyMolecularFunction | glutathione transmembrane transporter activity | 5.65e-04 | 7 | 105 | 2 | GO:0034634 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4-phosphate binding | 8.89e-04 | 36 | 105 | 3 | GO:0070273 | |
| GeneOntologyMolecularFunction | tripeptide transmembrane transporter activity | 9.63e-04 | 9 | 105 | 2 | GO:0042937 | |
| GeneOntologyMolecularFunction | ATPase-coupled lipid transmembrane transporter activity | 9.63e-04 | 9 | 105 | 2 | GO:0034040 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 1.20e-03 | 10 | 105 | 2 | GO:0043225 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | ITGA11 SEPTIN9 CAPZA1 ITGA6 MYO1B ACTN4 ACTN3 CD200R1 RACK1 CSNK1D | 1.23e-03 | 599 | 105 | 10 | GO:0050839 |
| GeneOntologyBiologicalProcess | negative regulation of smoothened signaling pathway | 5.67e-05 | 42 | 103 | 4 | GO:0045879 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphatidylcholine metabolic process | 7.38e-05 | 3 | 103 | 2 | GO:0150173 | |
| GeneOntologyBiologicalProcess | maintenance of Golgi location | 7.38e-05 | 3 | 103 | 2 | GO:0051684 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphatidylcholine biosynthetic process | 7.38e-05 | 3 | 103 | 2 | GO:2001247 | |
| GeneOntologyCellularComponent | pseudopodium | 9.25e-05 | 18 | 104 | 3 | GO:0031143 | |
| GeneOntologyCellularComponent | focal adhesion | 3.02e-04 | 431 | 104 | 9 | GO:0005925 | |
| GeneOntologyCellularComponent | cell-substrate junction | 3.69e-04 | 443 | 104 | 9 | GO:0030055 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 4.67e-04 | 129 | 104 | 5 | GO:0030863 | |
| GeneOntologyCellularComponent | actin cytoskeleton | SORBS2 SEPTIN9 CAPN2 CAPZA1 CAPZA2 MYO1B ACTN4 ACTN3 TTC17 LIMCH1 | 5.98e-04 | 576 | 104 | 10 | GO:0015629 |
| GeneOntologyCellularComponent | F-actin capping protein complex | 8.63e-04 | 9 | 104 | 2 | GO:0008290 | |
| GeneOntologyCellularComponent | clathrin complex | 8.63e-04 | 9 | 104 | 2 | GO:0071439 | |
| Domain | CH | 2.80e-05 | 65 | 102 | 5 | SM00033 | |
| Domain | DUF3402 | 2.95e-05 | 2 | 102 | 2 | PF11882 | |
| Domain | DUF4757 | 2.95e-05 | 2 | 102 | 2 | PF15949 | |
| Domain | N1221 | 2.95e-05 | 2 | 102 | 2 | PF07923 | |
| Domain | DUF4757 | 2.95e-05 | 2 | 102 | 2 | IPR031865 | |
| Domain | DUF3402 | 2.95e-05 | 2 | 102 | 2 | IPR021819 | |
| Domain | DUF3402 | 2.95e-05 | 2 | 102 | 2 | SM01293 | |
| Domain | N1221 | 2.95e-05 | 2 | 102 | 2 | SM01292 | |
| Domain | N1221 | 2.95e-05 | 2 | 102 | 2 | IPR012486 | |
| Domain | CH | 4.02e-05 | 70 | 102 | 5 | PF00307 | |
| Domain | - | 4.31e-05 | 71 | 102 | 5 | 1.10.418.10 | |
| Domain | CH | 4.92e-05 | 73 | 102 | 5 | PS50021 | |
| Domain | CH-domain | 5.61e-05 | 75 | 102 | 5 | IPR001715 | |
| Domain | F_ACTIN_CAPPING_A_1 | 8.83e-05 | 3 | 102 | 2 | PS00748 | |
| Domain | F_ACTIN_CAPPING_A_2 | 8.83e-05 | 3 | 102 | 2 | PS00749 | |
| Domain | F-actin_cap_A | 8.83e-05 | 3 | 102 | 2 | PF01267 | |
| Domain | CapZ_alpha | 8.83e-05 | 3 | 102 | 2 | IPR002189 | |
| Domain | F-actin_cap_asu_CS | 8.83e-05 | 3 | 102 | 2 | IPR017865 | |
| Domain | AAA+_ATPase | 1.39e-04 | 144 | 102 | 6 | IPR003593 | |
| Domain | AAA | 1.39e-04 | 144 | 102 | 6 | SM00382 | |
| Domain | HSA | 1.76e-04 | 4 | 102 | 2 | SM00573 | |
| Domain | HSA | 1.76e-04 | 4 | 102 | 2 | PS51204 | |
| Domain | HSA_dom | 1.76e-04 | 4 | 102 | 2 | IPR014012 | |
| Domain | HSA | 1.76e-04 | 4 | 102 | 2 | PF07529 | |
| Domain | Actinin_actin-bd_CS | 2.59e-04 | 23 | 102 | 3 | IPR001589 | |
| Domain | ACTININ_2 | 2.59e-04 | 23 | 102 | 3 | PS00020 | |
| Domain | ACTININ_1 | 2.59e-04 | 23 | 102 | 3 | PS00019 | |
| Domain | EF-hand_Ca_insen | 4.37e-04 | 6 | 102 | 2 | IPR014837 | |
| Domain | EFhand_Ca_insen | 4.37e-04 | 6 | 102 | 2 | PF08726 | |
| Domain | P-loop_NTPase | ABCC1 HBS1L EP400 SEPTIN9 RNF213 ABCC9 MYO1B ABCG4 KIF2B SMARCA4 DNAH9 YME1L1 AGAP3 | 7.08e-04 | 848 | 102 | 13 | IPR027417 |
| Domain | ABC_transporter_CS | 1.56e-03 | 42 | 102 | 3 | IPR017871 | |
| Domain | SM22_calponin | 1.57e-03 | 11 | 102 | 2 | IPR003096 | |
| Domain | ABC_tran | 2.29e-03 | 48 | 102 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 2.29e-03 | 48 | 102 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 2.43e-03 | 49 | 102 | 3 | PS00211 | |
| Domain | - | ABCC1 HBS1L EP400 SEPTIN9 RNF213 ABCC9 ABCG4 SMARCA4 DNAH9 YME1L1 AGAP3 | 2.51e-03 | 746 | 102 | 11 | 3.40.50.300 |
| Domain | ABC_transporter-like | 2.57e-03 | 50 | 102 | 3 | IPR003439 | |
| Domain | Integrin_alpha-2 | 4.27e-03 | 18 | 102 | 2 | IPR013649 | |
| Domain | Integrin_alpha2 | 4.27e-03 | 18 | 102 | 2 | PF08441 | |
| Domain | Integrin_alpha | 4.27e-03 | 18 | 102 | 2 | IPR000413 | |
| Domain | INTEGRIN_ALPHA | 4.27e-03 | 18 | 102 | 2 | PS00242 | |
| Domain | Int_alpha_beta-p | 4.75e-03 | 19 | 102 | 2 | IPR013519 | |
| Domain | Int_alpha | 4.75e-03 | 19 | 102 | 2 | SM00191 | |
| Domain | C2 | 5.78e-03 | 131 | 102 | 4 | PF00168 | |
| Domain | FG_GAP | 6.35e-03 | 22 | 102 | 2 | PS51470 | |
| Domain | C2 | 6.76e-03 | 137 | 102 | 4 | SM00239 | |
| Domain | Spectrin | 6.93e-03 | 23 | 102 | 2 | PF00435 | |
| Domain | FG-GAP | 7.54e-03 | 24 | 102 | 2 | PF01839 | |
| Domain | FG-GAP | 7.54e-03 | 24 | 102 | 2 | IPR013517 | |
| Domain | ABC_membrane | 7.54e-03 | 24 | 102 | 2 | PF00664 | |
| Domain | Integrin_dom | 8.16e-03 | 25 | 102 | 2 | IPR032695 | |
| Domain | PH | 8.44e-03 | 229 | 102 | 5 | PF00169 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HBS1L EP400 RB1 SEPTIN9 CAPN2 CAPZA1 CAPZA2 AAK1 MYO1B ACTN4 ACSL3 LRPPRC AP2S1 NUP155 RACK1 SLC25A1 CLTC SMARCA4 WDFY3 YME1L1 TOP1 PCK2 | 1.09e-10 | 1353 | 106 | 22 | 29467282 |
| Pubmed | SORBS2 SEPTIN9 CAPZA1 CAPZA2 AAK1 ACTN4 ACTN3 NT5DC3 NDUFS8 STRIP1 LRPPRC AP2S1 RACK1 LMO7 CLMN CSNK1D CLTC OSBPL8 SMARCA4 LIMCH1 TOP1 AGAP3 | 3.14e-10 | 1431 | 106 | 22 | 37142655 | |
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 3.16e-09 | 118 | 106 | 8 | 27377895 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | HBS1L VRK1 SEPTIN9 AAK1 MYO1B NDUFS8 STRIP1 ACSL3 AP2S1 RACK1 SLC25A1 OSBPL8 TOP1 | 4.32e-09 | 498 | 106 | 13 | 36634849 |
| Pubmed | GAD2 ZSWIM8 SORBS2 IFT172 CAPZA2 ACTN4 SCYL2 OTOF LMO7 CLTC OSBPL8 SMARCA4 TTC17 WDFY3 HARS1 MORC3 YME1L1 TOP1 AGAP3 | 1.13e-08 | 1285 | 106 | 19 | 35914814 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | CAPZA1 CAPZA2 MYO1B ACTN4 LRPPRC AP2S1 RACK1 LMO7 SLC25A1 CLTC OSBPL8 LIMCH1 TOP1 | 2.61e-08 | 580 | 106 | 13 | 35676659 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | SEPTIN9 ITGA6 MYO1B ACTN4 ACSL3 LRPPRC NUP155 RACK1 LMO7 CLTC LIMCH1 PCK2 | 2.65e-08 | 477 | 106 | 12 | 31300519 |
| Pubmed | EP400 SEPTIN9 CAPZA2 AAK1 MYO1B ACTN3 FKBP11 AP2S1 RACK1 LMO7 CSNK1D SLC25A1 CLTC OSBPL8 SMARCA4 LIMCH1 HARS1 TOP1 PCK2 | 3.16e-08 | 1371 | 106 | 19 | 36244648 | |
| Pubmed | GAD2 SORBS2 SEPTIN9 CAPN2 AAK1 ACTN4 GABBR2 NT5DC3 ACSL3 LRPPRC AP2S1 RACK1 CSNK1E CLTC OSBPL8 PCK2 AGAP3 | 6.40e-08 | 1139 | 106 | 17 | 36417873 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | CAPN2 CAPZA1 CAPZA2 MYO1B ACTN4 ACTN3 ACSL3 LRPPRC RACK1 LMO7 CLTC LIMCH1 YME1L1 | 9.27e-08 | 647 | 106 | 13 | 26618866 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | RB1 IFT172 CAPZA1 CAPZA2 AAK1 ACTN4 COPS2 SCYL2 ACSL3 LRPPRC AP2S1 CEP120 METTL9 LMO7 MORC3 YME1L1 PCK2 AGAP3 | 9.82e-08 | 1321 | 106 | 18 | 27173435 |
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | 1.26e-07 | 264 | 106 | 9 | 32814769 | |
| Pubmed | 1.36e-07 | 191 | 106 | 8 | 33762435 | ||
| Pubmed | HBS1L SEPTIN9 CAPN2 MYO1B COPS2 NDUFS8 ACSL3 LRPPRC CEP120 NUP155 CLTC OSBPL8 | 1.51e-07 | 560 | 106 | 12 | 35241646 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | VRK1 SEPTIN9 CAPN2 CAPZA1 CAPZA2 AAK1 ITGA6 RNF213 ACTN4 COPS2 YARS2 ACSL3 LRPPRC NUP155 RACK1 SLC25A1 CLTC MAD2L1 | 1.63e-07 | 1367 | 106 | 18 | 32687490 |
| Pubmed | 2.65e-07 | 45 | 106 | 5 | 22114352 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HBS1L VRK1 CAPZA1 CAPZA2 MYO1B ACTN4 NDUFS8 YARS2 ACSL3 LRPPRC NUP155 RACK1 CSNK1E CLTC SMARCA4 CC2D2A HARS1 TOP1 | 3.00e-07 | 1425 | 106 | 18 | 30948266 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | ABCC1 RNF213 ACTN4 GALNT7 FKBP11 NT5DC3 NDUFS8 YARS2 ACSL3 LRPPRC AP2S1 NUP155 RACK1 METTL9 CLTC SMARCA4 TOP1 PCK2 | 3.90e-07 | 1451 | 106 | 18 | 30550785 |
| Pubmed | HBS1L SEPTIN9 GXYLT1 MYO1B ACTN4 GALNT7 NDUFS8 ACSL3 LRPPRC NUP155 RACK1 CSNK1D CLTC OSBPL8 TTC17 HARS1 TOP1 | 4.00e-07 | 1297 | 106 | 17 | 33545068 | |
| Pubmed | EP400 SEPTIN9 CAPZA1 CAPZA2 MYO1B ACTN4 RACK1 LMO7 CLTC SMARCA4 TTC17 | 4.45e-07 | 506 | 106 | 11 | 30890647 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | RNF213 NDUFS8 STRIP1 YARS2 SCYL2 ACSL3 LRPPRC NUP155 SLC25A40 CLMN CSNK1D CSNK1E CLTC OSBPL8 TTC17 YME1L1 TOP1 PCK2 | 6.07e-07 | 1496 | 106 | 18 | 32877691 |
| Pubmed | SORBS2 CAPZA1 CAPZA2 ACTN4 GABBR2 ACSL3 AP2S1 CSNK1D CSNK1E AGAP3 | 8.33e-07 | 430 | 106 | 10 | 32581705 | |
| Pubmed | SCFFBW7-mediated degradation of Brg1 suppresses gastric cancer metastasis. | 9.55e-07 | 7 | 106 | 3 | 30177679 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EP400 SEPTIN9 CDKN2AIP CAPZA1 CAPZA2 AAK1 MYO1B SCYL2 RACK1 CLMN SMARCA4 ELF2 TASOR TOP1 | 9.87e-07 | 934 | 106 | 14 | 33916271 |
| Pubmed | HBS1L CAPZA2 ACTN4 TEC GALNT7 COPS2 TBCCD1 TRNT1 RACK1 CLMN CSNK1E TEDDM1 CLTC OTULINL TASOR | 1.06e-06 | 1084 | 106 | 15 | 11544199 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 1.15e-06 | 344 | 106 | 9 | 36282215 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | SEPTIN9 CAPZA1 CAPZA2 MYO1B ACTN4 LRPPRC NUP155 RACK1 LMO7 SLC25A1 CLTC SMARCA4 LIMCH1 TOP1 | 1.19e-06 | 949 | 106 | 14 | 36574265 |
| Pubmed | ABCC1 SLC26A2 CAPZA2 ITGA6 GALNT7 SCYL2 ACSL3 NUP155 RACK1 CSNK1E SLC25A1 CLTC OSBPL8 TTC17 | 1.23e-06 | 952 | 106 | 14 | 38569033 | |
| Pubmed | 1.25e-06 | 177 | 106 | 7 | 26485645 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | SEPTIN9 CAPZA1 AAK1 ITGA6 MYO1B SCYL2 RACK1 LMO7 CLMN CSNK1D LIMCH1 | 1.30e-06 | 565 | 106 | 11 | 25468996 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SEPTIN9 CAPZA1 CAPZA2 ITGA6 MYO1B ACTN4 LRPPRC NUP155 RACK1 LMO7 CSNK1D CSNK1E SLC25A1 CLTC SMARCA4 TOP1 | 1.34e-06 | 1257 | 106 | 16 | 36526897 |
| Pubmed | HBS1L CDKN2AIP CAPZA2 AAK1 MYO1B RACK1 LMO7 SLC25A1 HARS1 TOP1 | 1.65e-06 | 464 | 106 | 10 | 32457219 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SORBS2 AAK1 LRPPRC LMO7 CLMN CSNK1D CSNK1E SLC25A1 OSBPL8 LIMCH1 MORC3 UVRAG AGAP3 | 2.29e-06 | 861 | 106 | 13 | 36931259 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | HBS1L VRK1 EP400 CDKN2AIP CAPZA2 LRPPRC TRNT1 RACK1 SLC25A1 CLTC OSBPL8 SMARCA4 MORC3 TOP1 PCK2 MAD2L1 | 2.46e-06 | 1318 | 106 | 16 | 30463901 |
| Pubmed | WSB1 VRK1 SLF1 SLC26A2 CDKN2AIP COP1 YARS2 ACSL3 AP2S1 SLC12A1 RACK1 KIF2B PIK3R2 SLC25A1 CLTC ELF2 | 2.68e-06 | 1327 | 106 | 16 | 32694731 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EP400 SEPTIN9 CAPZA1 CAPZA2 MYO1B ACTN4 ACSL3 LRPPRC NUP155 RACK1 LMO7 CLTC SMARCA4 TOP1 | 2.88e-06 | 1024 | 106 | 14 | 24711643 |
| Pubmed | Identification of 14-3-3epsilon substrates from embryonic murine brain. | 3.33e-06 | 132 | 106 | 6 | 16944949 | |
| Pubmed | 3.58e-06 | 295 | 106 | 8 | 26209609 | ||
| Pubmed | ABCC1 RB1 CDKN2AIP MYO1B COPS2 LRPPRC AP2S1 PIK3R2 CLTC SMARCA4 YME1L1 | 3.94e-06 | 634 | 106 | 11 | 34591612 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SORBS2 EP400 SEPTIN9 AAK1 STRIP1 ACSL3 LMO7 CSNK1E CLTC SMARCA4 ELF2 LIMCH1 | 4.42e-06 | 774 | 106 | 12 | 15302935 |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 4.93e-06 | 411 | 106 | 9 | 35182466 | |
| Pubmed | The proximal signaling network of the BCR-ABL1 oncogene shows a modular organization. | 5.10e-06 | 81 | 106 | 5 | 20697350 | |
| Pubmed | ZSWIM8 MYO1B ACTN4 ACSL3 LRPPRC NUP155 RACK1 CLTC OSBPL8 SMARCA4 TOP1 | 5.21e-06 | 653 | 106 | 11 | 22586326 | |
| Pubmed | SEPTIN9 CAPZA1 CAPZA2 MYO1B ACTN4 LRPPRC RACK1 LMO7 CSNK1D CSNK1E PIK3R2 SLC25A1 CLTC LIMCH1 TOP1 | 5.85e-06 | 1247 | 106 | 15 | 27684187 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | HBS1L SEPTIN9 CAPN2 CAPZA1 CAPZA2 ACTN4 NDUFS8 YARS2 LRPPRC NUP155 RACK1 SLC25A1 CLTC OSBPL8 SMARCA4 TOP1 | 6.05e-06 | 1415 | 106 | 16 | 28515276 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | ABCC1 CAPN2 GALNT7 NDUFS8 ACSL3 LRPPRC NUP155 SLC25A1 CLTC OSBPL8 OTULINL YME1L1 PCK2 | 6.07e-06 | 942 | 106 | 13 | 31073040 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | CAPZA1 CAPZA2 MYO1B ACSL3 LRPPRC AP2S1 NUP155 RACK1 CSNK1D CSNK1E SLC25A1 CLTC SMARCA4 YME1L1 MAD2L1 | 6.43e-06 | 1257 | 106 | 15 | 37317656 |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | 7.35e-06 | 432 | 106 | 9 | 23455922 | |
| Pubmed | ABCC1 CAPZA1 CAPZA2 RNF213 MYO1B COPS2 NDUFS8 ACSL3 LRPPRC NUP155 METTL9 LMO7 CLTC OSBPL8 LIMCH1 PCK2 | 7.53e-06 | 1440 | 106 | 16 | 30833792 | |
| Pubmed | CAPZA1 CAPZA2 MYO1B ACTN4 ACTN3 ACSL3 LRPPRC TRNT1 LMO7 SLC25A1 DGKK CLTC CC2D2A LIMCH1 TASOR TOP1 | 7.67e-06 | 1442 | 106 | 16 | 35575683 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | CAPZA1 CAPZA2 ALG11 MYO1B COPS2 STRIP1 YARS2 LRPPRC AP2S1 CSNK1D CSNK1E SLC25A1 CLTC SMARCA4 MAD2L1 | 8.28e-06 | 1284 | 106 | 15 | 17353931 |
| Pubmed | An Interaction Network of the Human SEPT9 Established by Quantitative Mass Spectrometry. | 9.18e-06 | 43 | 106 | 4 | 30975701 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24424021 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 27940962 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 9632646 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 12588993 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19043076 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 23466492 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 25404202 | ||
| Pubmed | The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. | 9.20e-06 | 2 | 106 | 2 | 7923370 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 33486889 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22298706 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22981886 | ||
| Pubmed | Identification and cloning of the cDNA of a Rb-associated protein RAP140a. | 9.20e-06 | 2 | 106 | 2 | 18726359 | |
| Pubmed | 9.72e-06 | 159 | 106 | 6 | 30581152 | ||
| Pubmed | Role of the AP2 beta-appendage hub in recruiting partners for clathrin-coated vesicle assembly. | 9.77e-06 | 14 | 106 | 3 | 16903783 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | VRK1 SEPTIN9 CAPZA2 COPS2 RACK1 SLC25A1 CLTC SMARCA4 YME1L1 TOP1 PCK2 | 1.05e-05 | 704 | 106 | 11 | 29955894 |
| Pubmed | SEPTIN9 CAPZA1 ACTN4 LRPPRC AP2S1 NUP155 RACK1 PIK3R2 SLC25A1 CLTC TOP1 | 1.10e-05 | 707 | 106 | 11 | 19738201 | |
| Pubmed | HBS1L SEPTIN9 CAPZA1 AAK1 MYO1B SCYL2 LRPPRC NUP155 RACK1 OSBPL8 TOP1 | 1.11e-05 | 708 | 106 | 11 | 39231216 | |
| Pubmed | HBS1L EP400 CDKN2AIP AAK1 NDUFS8 STRIP1 AP2S1 RACK1 SLC25A40 SLC25A1 INTS15 OSBPL8 LIMCH1 TASOR YME1L1 AGAP3 | 1.22e-05 | 1497 | 106 | 16 | 31527615 | |
| Pubmed | VRK1 EP400 RB1 CDKN2AIP CAPN2 RNF213 COPS2 TRNT1 NUP155 RACK1 SMARCA4 TOP1 MAD2L1 | 1.33e-05 | 1014 | 106 | 13 | 32416067 | |
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | 1.39e-05 | 468 | 106 | 9 | 31056421 | |
| Pubmed | ABCC1 EP400 RNF213 STRIP2 STRIP1 CLMN CSNK1E OSBPL8 SMARCA4 TTC17 TASOR | 1.53e-05 | 733 | 106 | 11 | 34672954 | |
| Pubmed | RNF213 MYO1B LRPPRC RACK1 SLC25A1 CLTC SMARCA4 YME1L1 TOP1 PCK2 | 1.59e-05 | 601 | 106 | 10 | 33658012 | |
| Pubmed | HBS1L RNF213 COPS2 MINDY3 AP2S1 NUP155 SLC25A40 OSBPL8 MORC3 YME1L1 | 1.66e-05 | 604 | 106 | 10 | 38803224 | |
| Pubmed | 1.72e-05 | 481 | 106 | 9 | 28190767 | ||
| Pubmed | 1.81e-05 | 266 | 106 | 7 | 19380743 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 1.87e-05 | 486 | 106 | 9 | 30940648 | |
| Pubmed | CAPZA1 COPS2 SCYL2 LRPPRC NUP155 RACK1 SLC25A1 CLTC SMARCA4 TTC17 | 1.88e-05 | 613 | 106 | 10 | 22268729 | |
| Pubmed | 1.93e-05 | 488 | 106 | 9 | 31324722 | ||
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 2.09e-05 | 182 | 106 | 6 | 30711629 | |
| Pubmed | 2.19e-05 | 274 | 106 | 7 | 34244482 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | SEPTIN9 CAPZA1 CAPZA2 MYO1B ACTN4 LRPPRC RACK1 LMO7 CLTC TOP1 | 2.25e-05 | 626 | 106 | 10 | 33644029 |
| Pubmed | 2.65e-05 | 56 | 106 | 4 | 30022168 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 12761493 | ||
| Pubmed | Vertebrates have conserved capping protein alpha isoforms with specific expression patterns. | 2.76e-05 | 3 | 106 | 2 | 9331217 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 23438604 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 12270714 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 30429017 | ||
| Pubmed | The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4a. | 2.76e-05 | 3 | 106 | 2 | 19149898 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 10656685 | ||
| Pubmed | The STRIPAK complex components FAM40A and FAM40B regulate endothelial cell contractility via ROCKs. | 2.76e-05 | 3 | 106 | 2 | 30509168 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 25724478 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 25665722 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 32321936 | ||
| Pubmed | Casein kinase 1-epsilon or 1-delta required for Wnt-mediated intestinal stem cell maintenance. | 2.76e-05 | 3 | 106 | 2 | 28963394 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 31353086 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 8786104 | ||
| Pubmed | Characterization of mammary tumors from Brg1 heterozygous mice. | 2.76e-05 | 3 | 106 | 2 | 17637742 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 28306502 | ||
| Interaction | KCTD13 interactions | SORBS2 SEPTIN9 CAPN2 CAPZA1 CAPZA2 AAK1 ACTN4 ACTN3 NT5DC3 NDUFS8 STRIP1 LRPPRC AP2S1 RACK1 LMO7 CLMN CSNK1D CLTC OSBPL8 SMARCA4 LIMCH1 TOP1 AGAP3 | 6.23e-07 | 1394 | 105 | 23 | int:KCTD13 |
| Interaction | CIT interactions | HBS1L VRK1 SORBS2 EP400 SEPTIN9 CAPZA1 CAPZA2 RNF213 MYO1B ACTN4 ACTN3 YARS2 ACSL3 LRPPRC NUP155 RACK1 LMO7 SLC25A1 CLTC SMARCA4 HARS1 POLN TOP1 | 1.23e-06 | 1450 | 105 | 23 | int:CIT |
| Interaction | FBP1 interactions | RB1 CAPZA2 MYO1B ACTN3 ACSL3 LRPPRC RACK1 LMO7 CSNK1E SLC25A1 TOP1 | 2.04e-06 | 348 | 105 | 11 | int:FBP1 |
| Interaction | CTNNB1 interactions | ABCC1 SORBS2 EP400 CAPZA1 CAPZA2 MYO1B ACTN4 COPS2 LRPPRC RACK1 LMO7 CLMN CSNK1D CSNK1E SLC25A1 SMARCA4 LIMCH1 TOP1 | 4.34e-06 | 1009 | 105 | 18 | int:CTNNB1 |
| Interaction | SNCA interactions | HBS1L VRK1 SEPTIN9 AAK1 MYO1B NDUFS8 STRIP1 ACSL3 AP2S1 RACK1 CSNK1D SLC25A1 CLTC OSBPL8 TOP1 | 4.48e-06 | 716 | 105 | 15 | int:SNCA |
| Interaction | RAD18 interactions | SLF1 CAPZA1 CAPZA2 MYO1B ACTN4 ACSL3 LRPPRC LMO7 CLTC SMARCA4 POLN TOP1 | 4.64e-06 | 457 | 105 | 12 | int:RAD18 |
| Interaction | IGF1R interactions | DOK5 RNF213 GXYLT1 ACSL3 KL NUP155 RACK1 PIK3R2 CLTC OSBPL8 TTC17 MAD2L1 | 5.78e-06 | 467 | 105 | 12 | int:IGF1R |
| Interaction | DCAF11 interactions | 7.17e-06 | 136 | 105 | 7 | int:DCAF11 | |
| Interaction | ATG5 interactions | SEPTIN9 CDKN2AIP CAPN2 AAK1 RNF213 AP2S1 RACK1 CLTC WDFY3 AGAP3 | 1.26e-05 | 344 | 105 | 10 | int:ATG5 |
| Interaction | WWTR1 interactions | HBS1L EP400 RB1 CAPZA1 ARID5A SCYL2 RACK1 LMO7 SLC25A1 CLTC SMARCA4 | 1.27e-05 | 422 | 105 | 11 | int:WWTR1 |
| Interaction | FGD5 interactions | 1.29e-05 | 207 | 105 | 8 | int:FGD5 | |
| Interaction | AR interactions | EP400 RB1 CAPZA1 CAPZA2 RNF213 MYO1B ACTN4 COPS2 ARID5A ACSL3 RACK1 PIK3R2 CLTC SMARCA4 ELF2 LIMCH1 MORC3 | 1.40e-05 | 992 | 105 | 17 | int:AR |
| Interaction | C9orf78 interactions | HBS1L SEPTIN9 CAPN2 MYO1B COPS2 NDUFS8 ACSL3 LRPPRC CEP120 NUP155 CLTC OSBPL8 HARS1 | 2.03e-05 | 620 | 105 | 13 | int:C9orf78 |
| Interaction | MYO18A interactions | 2.96e-05 | 303 | 105 | 9 | int:MYO18A | |
| Interaction | PPP1CB interactions | SORBS2 RB1 SEPTIN9 CAPZA1 CAPZA2 RNF213 MYO1B ACTN4 LMO7 LIMCH1 TOP1 | 3.36e-05 | 469 | 105 | 11 | int:PPP1CB |
| Interaction | ELOB interactions | 5.36e-05 | 327 | 105 | 9 | int:ELOB | |
| Interaction | ECT2 interactions | CAPN2 EIF1AD CAPZA1 CAPZA2 MYO1B ACTN4 ACTN3 ACSL3 LRPPRC NUP155 RACK1 LMO7 CLTC DNAH9 TOP1 | 5.50e-05 | 887 | 105 | 15 | int:ECT2 |
| Interaction | BTF3 interactions | SEPTIN9 CAPZA1 CAPZA2 COP1 MYO1B ACTN4 LRPPRC CEP120 RACK1 LMO7 CLTC LIMCH1 TOP1 MAD2L1 | 6.84e-05 | 799 | 105 | 14 | int:BTF3 |
| Interaction | INS interactions | HBS1L RB1 CDKN2AIP CAPZA2 AAK1 MYO1B RACK1 LMO7 SLC25A1 HARS1 TOP1 | 8.35e-05 | 519 | 105 | 11 | int:INS |
| Interaction | CAPZA2 interactions | SORBS2 CAPZA1 CAPZA2 MYO1B ACTN4 LRPPRC LMO7 CSNK1E CLTC LIMCH1 | 8.35e-05 | 430 | 105 | 10 | int:CAPZA2 |
| Interaction | SLC6A4 interactions | SORBS2 CAPZA1 CAPZA2 ACTN4 GABBR2 ACSL3 AP2S1 CSNK1D CSNK1E AGAP3 | 9.54e-05 | 437 | 105 | 10 | int:SLC6A4 |
| Interaction | ATG16L1 interactions | VRK1 CDKN2AIP CAPZA1 CAPZA2 ACTN4 CCDC168 TEC STRIP1 SCYL2 AP2S1 RACK1 SLC25A1 CLTC OSBPL8 WDFY3 YME1L1 TOP1 | 1.01e-04 | 1161 | 105 | 17 | int:ATG16L1 |
| Interaction | CHMP4B interactions | SORBS2 CAPZA1 CAPZA2 MYO1B ACTN4 ACTN3 ACSL3 LRPPRC LMO7 SLC25A1 CLTC OSBPL8 TOP1 | 1.04e-04 | 727 | 105 | 13 | int:CHMP4B |
| Interaction | SYNE3 interactions | SORBS2 GXYLT1 SCYL2 ACSL3 NUP155 LMO7 CLMN OSBPL8 TTC17 OTULINL | 1.09e-04 | 444 | 105 | 10 | int:SYNE3 |
| Interaction | PPP1CC interactions | SORBS2 RB1 CAPZA1 CAPZA2 AAK1 MYO1B RACK1 LMO7 CLMN CSNK1E CLTC TTC17 TOP1 | 1.20e-04 | 738 | 105 | 13 | int:PPP1CC |
| Interaction | ATF3 interactions | 1.33e-04 | 94 | 105 | 5 | int:ATF3 | |
| Interaction | FRK interactions | 1.33e-04 | 50 | 105 | 4 | int:FRK | |
| Interaction | NINL interactions | CAPZA1 CAPZA2 SCYL2 LRPPRC RACK1 LMO7 PIK3R2 CLTC CC2D2A TTC17 | 1.40e-04 | 458 | 105 | 10 | int:NINL |
| Interaction | DBNDD1 interactions | 1.60e-04 | 4 | 105 | 2 | int:DBNDD1 | |
| Interaction | NAA40 interactions | EP400 SEPTIN9 CDKN2AIP CAPZA1 CAPZA2 AAK1 MYO1B SCYL2 RACK1 CLMN SMARCA4 ELF2 LIMCH1 TASOR TOP1 | 1.63e-04 | 978 | 105 | 15 | int:NAA40 |
| Interaction | CSNK1A1 interactions | 1.71e-04 | 381 | 105 | 9 | int:CSNK1A1 | |
| Interaction | CDH1 interactions | SEPTIN9 CAPZA1 AAK1 ITGA6 MYO1B ACTN4 SCYL2 LRPPRC RACK1 LMO7 CLMN CSNK1D LIMCH1 | 1.78e-04 | 768 | 105 | 13 | int:CDH1 |
| Interaction | PPP2R1B interactions | 1.86e-04 | 159 | 105 | 6 | int:PPP2R1B | |
| Interaction | MYLK2 interactions | 1.86e-04 | 101 | 105 | 5 | int:MYLK2 | |
| Interaction | RUFY1 interactions | RUBCNL CAPN2 CAPZA1 RNF213 MYO1B NDUFS8 LRPPRC SLC25A1 CLTC YME1L1 | 1.91e-04 | 476 | 105 | 10 | int:RUFY1 |
| Interaction | RHOF interactions | ABCC1 SLC26A2 ITGA6 ACTN4 YARS2 ACSL3 NUP155 CSNK1E PIK3R2 SLC25A1 CLTC OSBPL8 | 2.00e-04 | 673 | 105 | 12 | int:RHOF |
| Interaction | PINK1 interactions | SEPTIN9 ITGA6 MYO1B ACTN4 ACSL3 LRPPRC NUP155 RACK1 LMO7 CLTC LIMCH1 PCK2 | 2.17e-04 | 679 | 105 | 12 | int:PINK1 |
| Interaction | CFD interactions | ABCC1 RNF213 ACTN4 GALNT7 FKBP11 NT5DC3 NDUFS8 YARS2 ACSL3 LRPPRC AP2S1 NUP155 RACK1 METTL9 CLTC SMARCA4 TOP1 PCK2 | 2.18e-04 | 1360 | 105 | 18 | int:CFD |
| Interaction | PPP2CA interactions | WSB1 EP400 COP1 STRIP2 STRIP1 TBCCD1 LRPPRC ZNF550 RACK1 INTS15 | 2.19e-04 | 484 | 105 | 10 | int:PPP2CA |
| Interaction | UQCC1 interactions | 2.23e-04 | 105 | 105 | 5 | int:UQCC1 | |
| Interaction | CSNK1E interactions | 2.24e-04 | 311 | 105 | 8 | int:CSNK1E | |
| Interaction | CDK9 interactions | RB1 SEPTIN9 CAPZA1 CAPZA2 ACTN4 NUP155 RACK1 LMO7 CSNK1D SLC25A1 CLTC TOP1 | 2.35e-04 | 685 | 105 | 12 | int:CDK9 |
| Interaction | BRCA1 interactions | ABCC1 SLF1 RB1 SEPTIN9 CDKN2AIP CAPZA1 ACTN3 GPR161 NUP155 RACK1 CSNK1D CLTC SMARCA4 MORC3 POLN USH2A TOP1 | 2.41e-04 | 1249 | 105 | 17 | int:BRCA1 |
| Interaction | RMDN3 interactions | 2.44e-04 | 315 | 105 | 8 | int:RMDN3 | |
| Interaction | ACTN4 interactions | 2.45e-04 | 400 | 105 | 9 | int:ACTN4 | |
| Interaction | ACTC1 interactions | EP400 SEPTIN9 CAPZA1 CAPZA2 MYO1B ACTN4 SCYL2 RACK1 LMO7 CLTC SMARCA4 TTC17 | 2.64e-04 | 694 | 105 | 12 | int:ACTC1 |
| Interaction | FAM199X interactions | 2.91e-04 | 25 | 105 | 3 | int:FAM199X | |
| Interaction | SYVN1 interactions | 2.95e-04 | 324 | 105 | 8 | int:SYVN1 | |
| Interaction | RND1 interactions | 3.06e-04 | 246 | 105 | 7 | int:RND1 | |
| Interaction | HDAC6 interactions | EP400 CAPZA1 CAPZA2 MYO1B ACTN4 LRPPRC AP2S1 RACK1 LMO7 SLC25A1 CLTC OSBPL8 LIMCH1 TOP1 | 3.28e-04 | 929 | 105 | 14 | int:HDAC6 |
| Interaction | SOCS1 interactions | 3.31e-04 | 177 | 105 | 6 | int:SOCS1 | |
| Interaction | HSF1 interactions | EP400 ACTN4 ACSL3 LRPPRC RACK1 SLC25A1 CLTC SMARCA4 LIMCH1 TOP1 MAD2L1 | 3.34e-04 | 609 | 105 | 11 | int:HSF1 |
| Interaction | PML interactions | HBS1L EP400 RB1 SEPTIN9 AAK1 COP1 RNF213 LRPPRC LMO7 CSNK1D SMARCA4 ELF2 MORC3 AGAP3 | 3.42e-04 | 933 | 105 | 14 | int:PML |
| Interaction | FLT1 interactions | 3.51e-04 | 179 | 105 | 6 | int:FLT1 | |
| Interaction | MYO19 interactions | 3.53e-04 | 252 | 105 | 7 | int:MYO19 | |
| Interaction | FBXO6 interactions | CAPZA1 ITGA6 COPS2 SCYL2 LRPPRC NUP155 RACK1 SLC25A1 CLTC SMARCA4 TTC17 MAD2L1 | 3.55e-04 | 717 | 105 | 12 | int:FBXO6 |
| Interaction | KIF20A interactions | CAPZA1 CAPZA2 MYO1B ACTN4 ACTN3 LRPPRC NUP155 RACK1 LMO7 CSNK1D CLTC SMARCA4 YME1L1 TOP1 MAD2L1 | 3.57e-04 | 1052 | 105 | 15 | int:KIF20A |
| Interaction | STAP1 interactions | 3.67e-04 | 27 | 105 | 3 | int:STAP1 | |
| Interaction | EGLN3 interactions | ZSWIM8 HBS1L IFT172 CAPN2 CAPZA1 CAPZA2 MYO1B COPS2 NDUFS8 ACSL3 LRPPRC PIK3R2 SLC25A1 OSBPL8 TTC17 YME1L1 MAD2L1 | 3.70e-04 | 1296 | 105 | 17 | int:EGLN3 |
| Interaction | BICD2 interactions | 3.89e-04 | 426 | 105 | 9 | int:BICD2 | |
| Interaction | AAK1 interactions | 4.30e-04 | 121 | 105 | 5 | int:AAK1 | |
| Interaction | EED interactions | VRK1 EP400 SEPTIN9 CAPN2 CAPZA1 CAPZA2 MYO1B ACTN4 LRPPRC AP2S1 NUP155 RACK1 CLTC SMARCA4 LIMCH1 MORC3 TOP1 MAD2L1 | 4.55e-04 | 1445 | 105 | 18 | int:EED |
| Interaction | FOXO1 interactions | 4.66e-04 | 347 | 105 | 8 | int:FOXO1 | |
| Interaction | RND2 interactions | 4.91e-04 | 440 | 105 | 9 | int:RND2 | |
| Interaction | CUL4A interactions | WSB1 COP1 RNF213 COPS2 NT5DC3 LRPPRC NUP155 CSNK1E SMARCA4 TTC17 HARS1 UVRAG PCK2 | 4.94e-04 | 854 | 105 | 13 | int:CUL4A |
| Interaction | SIRT7 interactions | ZSWIM8 RB1 MYO1B ACTN4 ACSL3 LRPPRC NUP155 RACK1 CLTC OSBPL8 SMARCA4 TOP1 | 4.94e-04 | 744 | 105 | 12 | int:SIRT7 |
| Interaction | HIF1A interactions | 4.99e-04 | 441 | 105 | 9 | int:HIF1A | |
| Interaction | SYNPO interactions | 5.09e-04 | 192 | 105 | 6 | int:SYNPO | |
| Interaction | ROR1 interactions | 5.17e-04 | 126 | 105 | 5 | int:ROR1 | |
| Interaction | ALK interactions | 5.46e-04 | 271 | 105 | 7 | int:ALK | |
| Interaction | FNDC5 interactions | ABCC1 RNF213 ACTN4 GALNT7 FKBP11 NT5DC3 NDUFS8 YARS2 ACSL3 LRPPRC AP2S1 NUP155 RACK1 METTL9 CLTC SMARCA4 TOP1 PCK2 | 5.57e-04 | 1470 | 105 | 18 | int:FNDC5 |
| GeneFamily | Actinins | 8.57e-05 | 4 | 69 | 2 | 1112 | |
| GeneFamily | ATP binding cassette subfamily C | 1.09e-03 | 13 | 69 | 2 | 807 | |
| GeneFamily | Dyneins, axonemal | 1.88e-03 | 17 | 69 | 2 | 536 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 2.11e-03 | 18 | 69 | 2 | 1160 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 2.61e-03 | 20 | 69 | 2 | 1371 | |
| GeneFamily | WD repeat domain containing | 3.25e-03 | 262 | 69 | 5 | 362 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOK5 ABCC1 VRK1 RB1 SEPTIN9 ITGA6 MYO1B ACSL3 LRPPRC OSBPL8 WDFY3 TASOR UVRAG TOP1 | 8.25e-06 | 856 | 105 | 14 | M4500 |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_ALM_Oprk1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.80e-06 | 47 | 106 | 4 | b83e9a0f8db3f1581c5621f9d835ae2423ba0978 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-06 | 187 | 106 | 6 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-06 | 189 | 106 | 6 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.30e-06 | 195 | 106 | 6 | 3d6d3de8ada6dce3dc789c15b50cc066e7100496 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-06 | 196 | 106 | 6 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.44e-06 | 200 | 106 | 6 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.97e-05 | 167 | 106 | 5 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | Hippocampus|World / BrainAtlas - Mouse McCarroll V32 | 6.37e-05 | 176 | 106 | 5 | f120a703f6d2f2d5f55eae1aea2e6382a485828f | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 177 | 106 | 5 | e73e2b6a72630bb56ac2af1cdeedc8f0f828f390 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-05 | 177 | 106 | 5 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.90e-05 | 179 | 106 | 5 | 55fde77dae7f9e7f3431c3185d14212a25af83df | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.90e-05 | 179 | 106 | 5 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 7.09e-05 | 180 | 106 | 5 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-05 | 181 | 106 | 5 | 22363c5835dd6cef8f895ab9362e0837d92b15b1 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 182 | 106 | 5 | 9465238ac806fce46dfe1a141e83893f23eb4afb | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.66e-05 | 183 | 106 | 5 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.66e-05 | 183 | 106 | 5 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 8.70e-05 | 188 | 106 | 5 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | facs-MAT-Fat-18m-Endothelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-05 | 190 | 106 | 5 | 34e56c5e7ea6a8f227dbaefe73cbb8818d18b523 | |
| ToppCell | facs-MAT-Fat-18m-Endothelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-05 | 190 | 106 | 5 | 14cdb660ad3aabcf49572173e7628d8b99dcbe6f | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-05 | 190 | 106 | 5 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | facs-MAT-Fat-18m-Endothelial-endothelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-05 | 190 | 106 | 5 | 9aaa48f3aad813c87a45efdbb67d255c94f6e6a4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.60e-05 | 192 | 106 | 5 | fee99ca7e658963acf968aa724ef8c96cfc00a5d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 194 | 106 | 5 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 1.01e-04 | 194 | 106 | 5 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-CD8_low_T|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.01e-04 | 194 | 106 | 5 | 11eb317f66cbced1cedadd6daba443c4d832c49f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-04 | 195 | 106 | 5 | 68f4cc84b5ae7f4159b780c78e4b66c94211779a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-04 | 195 | 106 | 5 | 2a1863f4b9fe73c30b0b1acf9b12fc98ef65040f | |
| ToppCell | critical-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.06e-04 | 196 | 106 | 5 | c861f017aa9050282aa81c5a445bae399df00e4f | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.06e-04 | 196 | 106 | 5 | 6731fef8c148b6681d6ed38afdf23c8213e0bbbe | |
| ToppCell | Leuk-UTI-Myeloid-cDC2|Leuk-UTI / Disease, Lineage and Cell Type | 1.06e-04 | 196 | 106 | 5 | 50465a082f03201936733c55af73bc32e1bdd024 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-04 | 196 | 106 | 5 | eb68f7954e7c2f86d05e740e95b6e74805a6053f | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.06e-04 | 196 | 106 | 5 | 6856317cd0cdcb88fe54b4ae905d91e13495b1c4 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 197 | 106 | 5 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.08e-04 | 197 | 106 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | ASK428-Epithelial-Type_1|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.08e-04 | 197 | 106 | 5 | 9ae6661c307791c3f0ecd3d378e3d917565e5498 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Pericytes|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.08e-04 | 197 | 106 | 5 | 608328608cef82adc867a449216839622253d486 | |
| ToppCell | ASK428-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.11e-04 | 198 | 106 | 5 | 0047a9ef7684230ac5179efea94461480e90bdaf | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.14e-04 | 199 | 106 | 5 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | VE-CD4-exh_CD4|VE / Condition, Cell_class and T cell subcluster | 1.14e-04 | 199 | 106 | 5 | 6b00a393ad06ae91bf135a54a53ad4de68956193 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.14e-04 | 199 | 106 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (06)_OLFM4+|World / shred by cell type by condition | 1.14e-04 | 199 | 106 | 5 | c773b9180dbfec9c19d4098dd43332e6f6050372 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.14e-04 | 199 | 106 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 1.14e-04 | 199 | 106 | 5 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 200 | 106 | 5 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| Disease | tyrosine-protein kinase TEC measurement | 7.63e-05 | 4 | 106 | 2 | EFO_0020830 | |
| Disease | focal segmental glomerulosclerosis 1 (implicated_via_orthology) | 1.27e-04 | 5 | 106 | 2 | DOID:0111128 (implicated_via_orthology) | |
| Disease | syndromic X-linked intellectual disability Najm type (implicated_via_orthology) | 2.65e-04 | 7 | 106 | 2 | DOID:0060807 (implicated_via_orthology) | |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 2.71e-04 | 35 | 106 | 3 | DOID:700 (implicated_via_orthology) | |
| Disease | Carcinoma, Small Cell | 4.53e-04 | 9 | 106 | 2 | C0262584 | |
| Disease | blood cobalt measurement | 4.92e-04 | 101 | 106 | 4 | EFO_0007577 | |
| Disease | Gastrointestinal Stromal Sarcoma | 6.51e-04 | 47 | 106 | 3 | C3179349 | |
| Disease | Jeune thoracic dystrophy | 6.88e-04 | 11 | 106 | 2 | C0265275 | |
| Disease | Gastrointestinal Stromal Tumors | 7.81e-04 | 50 | 106 | 3 | C0238198 | |
| Disease | Polydactyly | 8.54e-04 | 117 | 106 | 4 | C0152427 | |
| Disease | blood nickel measurement | 9.39e-04 | 120 | 106 | 4 | EFO_0007583 | |
| Disease | Short Rib-Polydactyly Syndrome | 9.72e-04 | 13 | 106 | 2 | C0036996 | |
| Disease | Disorder of eye | 1.03e-03 | 212 | 106 | 5 | C0015397 | |
| Disease | Saldino-Noonan Syndrome | 1.13e-03 | 14 | 106 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 1.13e-03 | 14 | 106 | 2 | C0024507 | |
| Disease | familial atrial fibrillation (is_implicated_in) | 1.13e-03 | 14 | 106 | 2 | DOID:0050650 (is_implicated_in) | |
| Disease | p-cresol sulfate measurement | 1.48e-03 | 16 | 106 | 2 | EFO_0010998 | |
| Disease | 1-Methylhistidine measurement | 1.68e-03 | 17 | 106 | 2 | EFO_0021543 | |
| Disease | cystathionine measurement | 2.10e-03 | 19 | 106 | 2 | EFO_0010474 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 2.10e-03 | 19 | 106 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | pentachlorophenol measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022071 | |
| Disease | parathion measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022070 | |
| Disease | potassium chromate measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022067 | |
| Disease | methoxychlor measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022055 | |
| Disease | aldrin measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022054 | |
| Disease | dicofol measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022060 | |
| Disease | disulfoton measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022062 | |
| Disease | dieldrin measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022061 | |
| Disease | endrin measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022064 | |
| Disease | endosulfan measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022063 | |
| Disease | heptachlor measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022066 | |
| Disease | ethion measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022056 | |
| Disease | diazinon measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022058 | |
| Disease | environmental exposure measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0008360 | |
| Disease | fibrinogen measurement, coronary artery disease | 2.35e-03 | 154 | 106 | 4 | EFO_0001645, EFO_0004623 | |
| Disease | DDT metabolite measurement | 2.43e-03 | 74 | 106 | 3 | EFO_0007886 | |
| Disease | Sarcoma | 2.57e-03 | 21 | 106 | 2 | C1261473 | |
| Disease | fetal hemoglobin measurement | 2.57e-03 | 21 | 106 | 2 | EFO_0004576 | |
| Disease | retinal vasculature measurement | 2.67e-03 | 517 | 106 | 7 | EFO_0010554 | |
| Disease | ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder) | 2.82e-03 | 22 | 106 | 2 | C1843687 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VLWCALRALQKKYPE | 81 | Q2TAA5 | |
| WKKKYVTLCDNGLLT | 386 | Q96P47 | |
| QLKLWNVGKPYCLRS | 621 | Q8NHY2 | |
| LRDYQKIGLDWLAKL | 1091 | Q96L91 | |
| KIGLDWLAKLYRKNL | 1096 | Q96L91 | |
| WLAKLYRKNLNGILA | 1101 | Q96L91 | |
| WRKRGYKTLLKCLSG | 76 | Q9H172 | |
| QINLWKIYKAVEKLG | 86 | Q03989 | |
| RLWFKTNTKLGKLYL | 146 | P61201 | |
| TKADIWALGCLLYKL | 241 | Q2M2I8 | |
| RTKIDWNKILSYKIG | 266 | P52907 | |
| VNILGKIALWITYGK | 176 | Q9BYG8 | |
| KEGLLLWCQRKTAPY | 166 | O43707 | |
| NEILKGIKLLKLYAW | 496 | O60706 | |
| LIQNRAGKTRLAKWY | 6 | P53680 | |
| LCSKLKDYGLWQLFR | 411 | Q7Z5Q5 | |
| YIQKKKELWGICIFI | 91 | P06400 | |
| LLAKELYRVFQKCWI | 341 | Q9H714 | |
| DKTIKLWNTLGVCKY | 126 | P63244 | |
| VGLIRWCVKAPLAYK | 241 | Q96N11 | |
| LTKWYKGLCLLEQID | 461 | Q9Y450 | |
| PLLAVADICKKYKIW | 346 | Q05329 | |
| KRWKLRYFLVQGQKL | 231 | Q5KSL6 | |
| IKRCLQTKWPYIELL | 421 | Q9H8M7 | |
| QLKDWLYKCSVQKLV | 71 | Q13257 | |
| KYRKNIWIKRGDFLI | 56 | Q8N9N8 | |
| LPFYQKVWLLKGLCD | 421 | Q5HYC2 | |
| NRLYKTVAWKLVAVG | 441 | Q9NXV6 | |
| GLIRKLPKYNNCWLA | 81 | Q16822 | |
| KKGTRIIIWNLRSYK | 191 | Q14149 | |
| LPWQGLKAATKRQKY | 211 | P48730 | |
| LKKYKLNITWGDQDL | 306 | Q4G148 | |
| VKNVLITLYWLGRKA | 166 | Q8WWI1 | |
| WQLQKKKYRVLGINE | 181 | Q9H1A3 | |
| LLKLYKINGDWQRAD | 961 | P42704 | |
| IWLLKVNGCRKYKLN | 261 | Q8TD46 | |
| LGIYQRCWLVFKKAS | 21 | Q9P104 | |
| GNLWLRSLKALKYKS | 1086 | Q9UKX5 | |
| KEISNGKWLLYLVKV | 896 | P23229 | |
| RKSYQALALWKLLCE | 786 | O75694 | |
| FGKLRKYVELLKTQW | 196 | Q9NUU6 | |
| LGARQWKKAIYILDL | 891 | Q9UG01 | |
| LLYNKEKLLNNGDKW | 181 | O00217 | |
| KLWCVLKPGVLLIYK | 166 | Q9BZF1 | |
| RKIRDQYLVWLTQKG | 571 | O00459 | |
| IALIRANYWLKLVKG | 141 | Q9NYL4 | |
| LLCNYFLSLGKKAWL | 1371 | Q9P2K1 | |
| LQGIKWIKNKYRSEL | 3446 | Q9UFH2 | |
| KLHYKQQWGRALKEL | 841 | Q8N960 | |
| YIKLWNGLVKVFRNE | 261 | Q86SF2 | |
| CLLNLMQRDPYWKIK | 766 | Q86WZ0 | |
| RYIKWTQREKGIFKL | 226 | Q15723 | |
| SLVLKGKVEQKLRWY | 81 | P43080 | |
| ILKLLKHYQWKRVGT | 186 | O75899 | |
| PLIYGLWNKTVRKEL | 321 | Q8N6U8 | |
| GLRKVLNWLKFKYGD | 851 | Q9UEF7 | |
| QGIKWIKNKYGEDLR | 3471 | Q9NYC9 | |
| KRQDLLKTGQKWQYL | 3381 | Q8NDH2 | |
| KLGLKEFYILWTKIQ | 591 | P17655 | |
| LWDAGIKAELLYKKN | 431 | P12081 | |
| VYLSGINSWKKRLIR | 31 | Q92523 | |
| ILWRKTGTQKICLPY | 141 | Q5VVW2 | |
| GGKVYDLLNWKKKLQ | 361 | Q8N4N8 | |
| RKLKNVLVTIYWLGK | 121 | Q9UPQ0 | |
| VQAKVELYLWLGLSK | 906 | Q9HC10 | |
| VKLRTWLKNEFYKLG | 81 | Q5VZ72 | |
| NEILNGIKVLKLYAW | 506 | P33527 | |
| LGLSYCNGKWNKVII | 1791 | O75445 | |
| KIWGGKENIYQLLIE | 116 | Q9P2Y5 | |
| QLLIEWKVCLDGLKY | 126 | Q9P2Y5 | |
| WKVCLDGLKYLGQQI | 131 | Q9P2Y5 | |
| NLIAKYKGLLTWLEK | 56 | A5PLK6 | |
| ALLQQLREQWKKSGY | 406 | Q96Q11 | |
| KLLKLQTKYLGRQWR | 711 | Q9ULQ0 | |
| NYEILKKWLCEKSGL | 216 | Q8TBP6 | |
| LGKWRAQYKVAIKAI | 386 | P42680 | |
| ARLWKIAYGGLLKIV | 21 | Q5T9Z0 | |
| LLKIGKRNFYIIKWL | 461 | Q9Y2Z4 | |
| VTIQKVWKGYLQRKR | 211 | A6NCM1 | |
| LLWDKIHKLQKGQIY | 351 | Q86UY8 | |
| NGVLKQYQIKGLEWL | 751 | P51532 | |
| YQVNGKRILGRKTKW | 506 | Q9UHD8 | |
| LLKVQTKYLGRQWRK | 716 | Q5VSL9 | |
| CLGKILEYLDKWFVL | 511 | Q6P3W7 | |
| WKDCKLRIYVGGKIN | 936 | Q13621 | |
| ILLKRVDQNWYEGKI | 966 | O94875 | |
| YTLWKGQLLNKGKLL | 356 | Q9UK61 | |
| KEGLLLWCQRKTAPY | 161 | Q08043 | |
| RTKIDWNKILSYKIG | 266 | P47755 | |
| GKIFKKVILGQYNWL | 121 | O95573 | |
| KALLAWVQRKTRKYG | 191 | Q96JQ2 | |
| YRTDAKQKWLLLTGI | 156 | Q00610 | |
| WKALDKDQYLPRKLC | 1496 | Q63HN8 | |
| NCGAWDKKLLKQYRV | 951 | Q8IZQ1 | |
| LQWLPKYDLKKNILG | 96 | P50443 | |
| YRNTWDCGLQILKKE | 256 | P53007 | |
| WKLDRKLGIVCLLSY | 461 | Q71RS6 | |
| AALYWRVKGQGKKAI | 1021 | Q96AE7 | |
| WLLDLYAGNIKTLQK | 1006 | Q9BQI6 | |
| IQKWIRTRKLKYLGV | 96 | Q99986 | |
| GRTEILKWYLNKIKF | 511 | Q96TA2 | |
| KWLLGLAAKLGVNYV | 1701 | A7E2V4 | |
| KQCGKGFNRKWYLVR | 206 | Q7Z398 | |
| LAQIPQKVLWRYKGK | 326 | Q6UWM9 | |
| ACGKLQLAKDLAWLY | 61 | Q9NVR7 | |
| RIKIWDVYTGKLLLN | 151 | Q9Y6I7 | |
| LNYLDPRITVAWCKK | 721 | P11387 | |
| VKVKPLAYVCIFLWR | 201 | P51811 | |
| LPWQGLKAATKRQKY | 211 | P49674 | |
| DLATLIQKIYRGWKC | 706 | O43795 |